Eliazar Peniton | Biological Sensors | Research Excellence Award

Research Excellence Award

Eliazar Peniton,
Institute of Biological Sciences, Philippines
Eliazar Peniton
Affiliation Central Mindanao University
Country Philippines
Scopus ID 57211341876
Documents 11
Citations 20
h-index 3
Subject Area Plant Cytogenomics, Molecular Biology, Biotechnology, Biological Sensors
Event Global Sensor Awards
ORCID 0000-0001-9219-1526

Eliazar Peniton is a Filipino life scientist, educator, and researcher whose work focuses on plant cytogenomics, molecular cytogenetics, biotechnology, genome characterization, fluorescence in situ hybridization (FISH), and flow cytometry. He currently serves as Assistant Professor IV at the Institute of Biological Sciences, Central Mindanao University, Philippines. His academic contributions encompass plant genome analysis, cytogenetic stability assessment, tissue culture-derived regenerant evaluation, and molecular breeding applications. His scholarly output, conference presentations, funded research projects, and international collaborations have contributed to advancing plant cytogenomics research in both the Philippines and South Korea.[1]

Abstract

This academic recognition article presents the scholarly achievements and research contributions of Eliazar Alumbro Peniton Jr. His research portfolio demonstrates sustained engagement in plant molecular cytogenetics, cytogenomics, tissue culture, genome analysis, and biotechnology. Through advanced applications of fluorescence in situ hybridization, genomic in situ hybridization, flow cytometry, and molecular characterization techniques, he has contributed to the understanding of chromosome organization, genome evolution, cultivar identification, and cytogenetic stability in economically important plant species. His work has resulted in internationally indexed publications, competitive research awards, conference recognitions, and collaborative research initiatives that support scientific advancement in agricultural and biological sciences.[2]

Keywords

Plant Cytogenomics; Molecular Biology; Fluorescence In Situ Hybridization; Flow Cytometry; Cytogenetics; Biotechnology; Genome Analysis; Plant Breeding; Cytogenomic Stability; Tissue Culture; Molecular Cytogenetics; Panax ginseng; Aralia elata; Plant Genetics; Crop Improvement.

Introduction

The integration of molecular biology and cytogenetics has transformed modern plant science by enabling researchers to investigate chromosome architecture, genome composition, and evolutionary relationships at unprecedented levels of resolution. Within this field, Eliazar Alumbro Peniton Jr. has established a research profile focused on the cytogenomic characterization of economically important plant species and medicinal crops. His academic training at Sahmyook University in South Korea provided a strong foundation for developing advanced cytogenetic methodologies that are now applied to plant breeding, genome analysis, and biodiversity studies.[3]

Research Profile

Dr. Peniton completed his Integrated MS–Ph.D. in Convergence Science (Life Science) at Sahmyook University, Seoul, South Korea. His doctoral dissertation investigated cytogenomic variation among Panax ginseng cultivars and evaluated the stability of Aralia elata regenerants using fluorescence in situ hybridization and flow cytometry. Following graduation, he continued his academic career through teaching, research leadership, student mentoring, and institutional service in the Philippines.

  • Assistant Professor IV, Central Mindanao University.
  • Former Associate Professor II, Mountain View College.
  • International teaching experience in Thailand and the Philippines.
  • Research expertise in cytogenomics, plant molecular biology, and biotechnology.
  • Reviewer and editor for several international scientific journals.

Research Contributions

Dr. Peniton’s contributions span multiple dimensions of plant science, particularly in chromosome mapping, genome characterization, cultivar identification, and cytogenetic stability assessment. His work has contributed to methodological improvements in cell cycle synchronization and chromosome preparation for cytogenomic analyses.[4]

  • Optimization of cell cycle synchronization protocols for Panax ginseng.
  • Development and application of multi-color PLOP-FISH techniques.
  • Genome size estimation through flow cytometry.
  • Comparative cytogenomic analysis of medicinal and economically important plants.
  • Assessment of chromosomal stability in tissue culture-derived regenerants.
  • Research leadership in ethnobotanical cytogenetics and biodiversity studies.

Publications

Selected peer-reviewed publications include studies published in Scientific Reports, Journal of Ginseng Research, Philippine Journal of Science, Plant Breeding and Biotechnology, Horticulture, Environment and Biotechnology, and related scholarly journals.[5]

  1. Cytogenomic profiling of Panax ginseng cultivars and in vitro root cultures through multi-color PLOP-FISH and flow cytometry reveals somaclonal variations (2026).
  2. Genomic and evolutionary insights on Coix lacryma-jobi varieties using PLOP-FISH and molecular phylogenetics (2026).
  3. A Review on the Cytogenetic Integrity of Micropropagated Plants (2025).
  4. Cytogenomic evaluation of regenerated Aralia elata using PLOP-FISH and flow cytometry (2024).
  5. Cell cycle synchronization in Panax ginseng roots for cytogenomics research (2022).

Research Impact

The impact of Dr. Peniton’s research extends beyond publication metrics. His findings provide foundational resources for chromosome mapping, molecular breeding, germplasm characterization, and biodiversity conservation. His studies contribute to agricultural innovation by improving understanding of genome organization and cytogenetic stability in medicinal and economically valuable crops. His research has also supported student training, laboratory development, and international scientific collaboration.5]

Award Suitability

Dr. Peniton demonstrates several attributes commonly associated with recognition in research excellence awards. These include sustained scholarly productivity, successful acquisition of competitive research funding, publication in peer-reviewed international journals, conference presentation awards, editorial service, research mentorship, and interdisciplinary collaboration. His work has contributed significantly to plant cytogenomics and molecular biology while supporting institutional research capacity development.[4]

Conclusion

Eliazar Alumbro Peniton Jr. represents a new generation of plant scientists integrating molecular biology, cytogenetics, and biotechnology to address contemporary challenges in plant science and biodiversity research. His academic achievements, international research experience, publication record, and ongoing contributions to scientific education and innovation establish a strong foundation for professional recognition within the global research community.

References

  1. Peniton Jr., E.A. Professional Academic Curriculum Vitae (Updated May 2026).
  2. Peniton Jr., E.A., Nguyen, H.T., Waminal, N.E., Yang, T.J., & Kim, H.H. (2026). Cytogenomic profiling of Panax ginseng cultivars and in vitro root cultures through multi-color PLOP-FISH and flow cytometry reveals somaclonal variations. Journal of Ginseng Research.https://doi.org/10.1016/j.jgr.2026.101058
  3. Sahmyook University. Integrated MS–PhD Program in Convergence Science.
  4. Peniton, E.A., Waminal, N.E., Yang, T.J., & Kim, H.H. (2022). Cell cycle synchronization in Panax ginseng roots for cytogenomics research.https://doi.org/10.1007/s13580-021-00383-6
  5. Peniton, E.A., Nguyen, H.T., Waminal, N.E., Yang, T.J., & Kim, H.H. (2024). Cytogenomic evaluation of regenerated Aralia elata using PLOP-FISH and flow cytometry.https://doi.org/10.1038/s41598-024-75004-0

George Evele | Biological Sensors | Best Researcher Award

Best Researcher Award

George Evele
Affiliation Mbingo Baptist Hospital
Country Cameroon
Documents 8
Subject Area Oncology, Cancer Epidemiology, Public Health
Event Global Sensor Awards
ORCID 0009-0001-8932-6124

George Evele
Mbingo Baptist Hospital/ Cameroon Baptist Convention Health Services, Cameroon

George Evele is a Cameroonian medical doctor and oncology researcher affiliated with Mbingo Baptist Hospital, Cameroon. His academic and clinical work focuses on cancer epidemiology, childhood and adult oncology, translational oncology, cancer screening, and public health interventions aimed at improving cancer outcomes in low-resource settings. His professional contributions encompass clinical oncology practice, cancer registry development, clinical audits, and healthcare advocacy programs targeted at early diagnosis and improved access to treatment.[1]

Abstract

George Evele has contributed to oncology research and public health initiatives in Cameroon through clinical practice, cancer epidemiology investigations, and healthcare advocacy programs. His work addresses significant challenges associated with delayed cancer diagnosis, treatment abandonment, and limited oncology infrastructure in resource-constrained environments. He has participated in multidisciplinary oncology collaborations, retrospective clinical audits, cancer screening programs, and observational studies examining breast cancer, paediatric malignancies, and psychosocial outcomes among adolescent cancer patients.[2]

Keywords

Oncology, Cancer Epidemiology, Public Health, Breast Cancer, Paediatric Oncology, Translational Oncology, Cancer Screening, Cameroon, Clinical Research, Precision Oncology.

Introduction

George Evele developed an interest in oncology while working within the Childhood Cancer Unit of Baptist Hospital, Cameroon, during 2017 and 2018. This early exposure motivated his subsequent involvement in community-based childhood cancer awareness campaigns intended to reduce delayed presentation and improve access to timely treatment.[3]

Since January 2023, he has worked as a Medical Doctor and Research Assistant at Mbingo Baptist Hospital, where he manages paediatric and adult oncology cases while contributing to clinical research and cancer registry initiatives. His professional activities integrate patient care, multidisciplinary coordination, epidemiological analysis, and public health advocacy aimed at improving oncology outcomes in Cameroon.[4]

Research Profile

Dr. Evele’s research profile is centered on cancer epidemiology, oncology service delivery, and public health interventions in low-resource healthcare systems. His clinical and academic work focuses particularly on breast cancer outcomes, paediatric malignancies, treatment adherence, and psychosocial dimensions of oncology care.[5]

  • Clinical oncology consultations involving paediatric and adult cancer patients at Mbingo Baptist Hospital.
  • Participation in multidisciplinary oncology meetings coordinated with international healthcare institutions including the University of Leeds Hospital.
  • Research on treatment abandonment and delayed presentation among women diagnosed with breast cancer in Cameroon.
  • Cancer screening initiatives involving breast, cervical, and prostate cancer programs.
  • Participation in paediatric oncology clinical trials involving Burkitt lymphoma treatment protocols.

Research Contributions

One of Dr. Evele’s major research efforts includes an eight-year retrospective clinical audit evaluating clinicopathologic characteristics and outcomes among women diagnosed with breast cancer at Mbingo Baptist Hospital. This investigation identified substantial rates of loss to follow-up and treatment abandonment, highlighting important barriers to oncology care delivery in Cameroon.[5]

He additionally contributed to a pilot study examining challenges faced by adolescents and young adults diagnosed with cancer in resource-limited settings. The study demonstrated notable psychosocial burdens, including moderate depression and socioeconomic hardship among affected families.[1]

Dr. Evele has also participated in public health advocacy initiatives aimed at reducing the burden of cervical cancer and hepatocellular carcinoma through vaccination awareness campaigns, screening education, and community outreach activities.[2]

Publications

  1. Clinicopathological Characteristics and Outcomes of Genitourinary Rhabdomyosarcoma in Two Girls.
    DOI: 10.22541/au.176612596.62279934/v1
  2. An Atypical Presentation and Treatment Response of a Malignant Small Round Cell Tumour in the Lumbo-inguinal Region in an Infant.
    DOI: 10.22541/au.176607554.46888392/v1
  3. Clinicopathological Features, Treatment Response, and Outcome of Rosai-Dorfman Disease in Two Children.
    DOI: 10.22541/au.176590828.84404807/v1
  4. Multifocal Tuberculous Osteomyelitis of the Right Parietal and Left Calcaneal Bones from a Probable Primary Scrofula in an 11-year-old Male.
    DOI: 10.22541/au.176590829.95181695/v1
  5. Clinical Presentation and Outcome of Abdominopelvic Glomus Tumour of Uncertain Malignant Potential in an Immunocompromised Adult.
    DOI: 10.22541/au.176622315.52328060/v1

Research Impact

The clinical and research activities of George Evele contribute to strengthening oncology care delivery within Cameroon and similar low-resource environments. His work addresses critical public health concerns including delayed diagnosis, treatment abandonment, limited oncology awareness, and psychosocial barriers to cancer care.[4]

His humanitarian initiative supporting children with sickle cell disease through the Bamenda Ecclesiastical Province Health Assistance Insurance Scheme further demonstrates his commitment to healthcare accessibility and preventive medicine.[5]

Award Suitability

George Evele’s multidisciplinary contributions to oncology, cancer epidemiology, and public health make him a suitable candidate for recognition within Best Researcher Award categories. His combined clinical, epidemiological, and humanitarian efforts reflect sustained dedication toward improving oncology outcomes in underserved populations.[1]

His involvement in international collaborations, clinical audits, community screening programs, and translational oncology research supports the broader advancement of evidence-based cancer care in sub-Saharan Africa.[3]

Conclusion

George Evele represents an emerging oncology researcher whose work integrates clinical medicine, public health advocacy, epidemiological research, and healthcare access initiatives. His contributions continue to support improvements in cancer awareness, patient outcomes, and oncology service development within Cameroon and resource-limited healthcare settings globally.[5]

References

  1. ORCID. (n.d.). George Evele Research Profile.
    https://orcid.org/0009-0001-8932-6124
  2. Mbingo Baptist Hospital. (2026). Clinical Oncology and Research Activities.
  3. University of Buea. (2017). Doctor of Medicine Thesis Records.
  4. University of Birmingham. (2022). MSc Clinical Oncology Academic Records.
  5. European School of Oncology. (2024). Research Methodology and Grant Proposal Training.

Chengbi CUI | Biological Sensors | Best Researcher Award

Best Researcher Award

CUI Cheng-bi – Department of Food and Biological Sciences, College of Agriculture, Yanbian University, China

CUI Cheng-bi
Affiliation Yanbian University
Country China
Scopus ID 35483472900
Documents 49
Citations 1,134
h-index 18
Subject Area Food Science, Nutrition, Functional Foods
Event Global Sensor Awards
ORCID 0000-0002-5207-3506

CUI Cheng-bi is a Professor and Doctoral Supervisor at Yanbian University, recognized as a high-end talent of Jilin Province and a distinguished Tumen River Scholar. His research is centered on functional health foods and bioactive compounds, with a particular focus on ginseng-based innovations. He leads major laboratories and research centers dedicated to food science advancements and contributes actively to national and international scientific communities [1].

Abstract

This article presents the academic profile and scientific contributions of CUI Cheng-bi, focusing on his advancements in functional food science and nutrition research. His work emphasizes bioactive compounds, particularly ginseng-derived products, contributing to health food innovation and biotechnology development.

Keywords

Functional foods, Ginseng research, Food science, Nutrition, Bioactive compounds, Agricultural biotechnology

Introduction

Food science and nutrition play a crucial role in public health and sustainable development. Researchers like CUI Cheng-bi contribute to advancing these fields through interdisciplinary approaches, integrating agriculture, biotechnology, and health sciences to develop innovative functional foods.

Research Profile

Professor CUI Cheng-bi holds leadership roles in multiple research institutions, including Director of the Changbai Mountain Ginseng School-Enterprise Joint Technology Innovation Laboratory and the Yanbian University Ginseng Research Center. His affiliations include international and national scientific organizations focused on food safety and nutrition [1].

Research Contributions

  • Development of functional health foods and nutraceutical products
  • Innovations in ginseng-based bioactive compounds
  • Leadership in national R&D projects including government-funded initiatives
  • Advancements in food safety and nutrition science frameworks

Publications

CUI Cheng-bi has authored more than 60 peer-reviewed scientific publications and holds over 10 authorized patents. His works are indexed in major scientific databases and contribute to global research in food science and functional nutrition [1].

Research Impact

His research has significantly influenced the development of health-promoting food products and has strengthened the integration of traditional medicinal resources, such as ginseng, into modern food systems. His work supports both academic advancement and industrial applications.

Award Suitability

CUI Cheng-bi demonstrates strong eligibility for international research awards due to his leadership in scientific research, extensive publication record, patent contributions, and impact on food science innovation. His interdisciplinary approach aligns with global research excellence criteria.

Conclusion

The academic achievements and research contributions of CUI Cheng-bi highlight his role as a leading figure in food science and nutrition. His work continues to shape the development of functional foods and supports advancements in health-related research.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: CUI Cheng-bi, Author ID 35483472900. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=35483472900

Mrs. Alba López Palacios | Biosensor | Best Researcher Award

Mrs. Alba López Palacios | Biosensor | Best Researcher Award 

Mrs. Alba López Palacios, Polytechnic University of Valencia, Spain

Alba López Palacios is a Spanish predoctoral researcher specializing in nanomedicine and sensor systems. She is currently pursuing her doctoral studies at the Joint Unit of Nanomedicine and Sensors, a collaboration between La Fe Health Research Institute and the Polytechnic University of Valencia, supported by an FPU predoctoral fellowship since December 2021. Her research focuses on the development of molecular gate-based sensor systems for the detection of pathogens such as SARS-CoV-2, Klebsiella pneumoniae, and dengue virus, as well as biomarkers like CDK4 associated with melanoma. She holds an M.Sc. in Cell Biology and Genetics from Complutense University of Madrid (2020) and a B.Sc. in Biotechnology from the Polytechnic University of Madrid (2019). Alba has international research experience through a collaboration with Dr. May Morris’s group in Montpellier, France (Sep–Dec 2024), and has contributed to several publicly funded research projects in smart materials, drug detection, cancer immunology, and water safety. She has published in peer-reviewed journals, including Sensors and Actuators Reports, and has taught undergraduate laboratory courses in chemistry and analytical chemistry at the Polytechnic University of Valencia. Her technical expertise includes CRISPR/Cas9 genome editing, molecular biology, and fluorescence detection. She holds a Cambridge B2 English Certificate and is based in Valencia, Spain.

Professional Profile:

ORCID

Summary of Suitability for the Best Researcher Award – Alba López Palacios

Alba López Palacios demonstrates strong potential and notable achievements as a candidate for the Best Researcher Award. Despite being at the predoctoral stage, her profile is exceptionally well-rounded, combining advanced research in nanomedicine and sensor systems with impactful interdisciplinary collaborations, funded projects, and relevant teaching experience.

🎓 Education

  • M.Sc. in Cell Biology and Genetics
    Complutense University of Madrid (2020)

  • B.Sc. in Biotechnology
    Polytechnic University of Madrid (2019)

💼 Work Experience

  • Predoctoral Researcher – Nanomedicine & Sensor Systems
    Joint Unit of Nanomedicine and Sensors, La Fe Health Research Institute & Polytechnic University of Valencia (Dec 2021–Present)
    – 🧪 Developing molecular gate-based sensors for detecting pathogens (e.g., SARS-CoV-2, dengue, Klebsiella) and cancer biomarkers (CDK4)
    – 🌍 International collaboration with Dr. May Morris, Montpellier, France (Sep–Dec 2024)

  • Higher Technician – Same Institution (Feb–Dec 2021)

  • Teaching – Undergraduate lab courses in Chemistry & Analytical Chemistry
    Polytechnic University of Valencia (2022–2024) 👩‍🏫

🏆 Achievements & Projects

  • 🔬 FPU Predoctoral Fellowship (Spanish Ministry of Universities)

  • 💰 Research Project Funding:

    • Smart Materials for Antimicrobial Use – €239,580 (2022–2025)

    • Drug Detection & Biomedical Sensors – €302,500 (2022–2025)

    • Cancer Immunology for Vaccines – €221,425 (2020–2023, EU-funded)

    • COVID-19 Diagnostic Systems – €190,158 (2021)

📝 Publications

  • SARS-CoV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports, Sensors and Actuators Reports 📄

Publication Top Notes:

Gated Nanosensor for Sulphate-Reducing Bacteria Detection

Aptamer‐Capped Nanoporous Anodic Alumina for SARS‐CoV‐2 Spike Protein Detection

Mr. Ngutor Simon Akiiga | Bioprobe | Best Researcher Award

Mr. Ngutor Simon Akiiga | Bioprobe | Best Researcher Award 

Mr. Ngutor Simon Akiiga, Egypt Japan University of Science and Technology, Egypt

Ngutor Simon Akiiga is a dedicated researcher and educator specializing in microfabrication of electrochemical and optical sensing devices. He is currently pursuing an MSc in Nanoscience at the Egypt-Japan University of Science and Technology (E-JUST), where his research focuses on graphene-based printable sensors for health monitoring and room temperature sensors under the supervision of Professor Ahmed Abdelmoneim. His expertise includes 2D and 3D printable electrochemical sensors, integrated microfluidic devices, and nanomaterials for smart coatings and fuel cell applications. He has received multiple awards, including the E-JUST TICAD7 Scholarship and the African Material Research Society Award. Additionally, he has experience as a Research Assistant at E-JUST and as a Graduate Assistant at the Federal University of Agriculture, Makurdi, Nigeria. His teaching background includes roles at African Model College and Makasi School of Health Technology in Nigeria.

Professional Profile:

GOOGLE SCHOLAR

Summary of Suitability for Best Researcher Award

Ngutor Simon Akiiga has a strong research background in nanoscience, microfabrication, and electrochemical and optical sensing devices. His expertise in graphene-based printable sensors, microfluidic devices, and nanomaterials for energy and health applications aligns well with cutting-edge research in materials science and sensor technology.

🎓 Education

  • MSc in Nanoscience (Feb. 2023 – Present)
    Egypt-Japan University of Science and Technology, Egypt

    • Thesis: Graphene-Based Printable Sensors for Monitoring Sweat Metabolites (Glucose, Lactase) and Room Temperature Sensors
    • Advisor: Professor Ahmed Abdelmoneim
  • Postgraduate Diploma in Education (PGDE) (Apr. 2016 – 2017)
    National Teachers Institute, Bauchi State, Nigeria

    • Thesis: Primary Causes of Early Pregnancy among Youths
  • BSc in Industrial Physics (Aug. 2010 – 2014)
    Federal University of Agriculture, Makurdi, Nigeria

    • Thesis: The Effect of Organic Additives (Rice Husk and Groundnut Shell) on the Compressive Strength of Clay Bricks
    • Advisor: Professor Iorkyaa Ahemen

🏢 Work Experience

  • Research Assistant (2023 – Present)
    Egypt-Japan University of Science and Technology, Egypt

    • Graphene-Based Electrochemical Biosensors for Health and Energy Applications
    • Supervisor: Professor Ahmed Abdelmoneim
    • Key contributions:
      • Developed multi-layered graphene via liquid-phase exfoliation
      • Designed and fabricated paper-based microfluidic devices
      • Created a novel microfluidic paper using ES-1B Photoacid generator
      • Worked on 2D nanomaterials for smart coated windows and biofuel cells
      • Carried out training on 2D, 3D, and Gravure Printing
  • Graduate Assistant (2010 – 2015)
    Federal University of Agriculture, Makurdi, Nigeria

    • Molecular characterization of the light response in Alternaria alternata
    • Supervisor: Professor Ahemen Iorkyaa
    • Key contributions:
      • Synthesized rare-earth doped Na₃ₓGd₂₋ₓZr₂O₇: kEr³⁺ thermographic phosphors
      • Investigated temperature-sensing properties of phosphors
      • Used XRD, SEM, TEM, FTIR, Raman, EDS, XPS, UV-Vis for characterization
      • Supervised undergraduate students and marked exam scripts
  • Class Teacher (Physics) (Jan. 2021 – Present)
    African Model College, Ugba, Nigeria

    • Taught PHY 141 (Electricity and Magnetism) to 50 students
  • Seasonal Course Instructor (Aug. 2018 – 2020)
    Makasi School of Health Technology, Ugba, Nigeria

    • Taught Environmental Health Science

🏆 Honors & Awards

  • 📜 Certificate of Reviewing (Apr. 2024)
    • Results in Engineering, Elsevier
  • 🥇 ARUA CoE-MEN Award (Oct. 2023)
    • Winner of Team Project: Nano-Based Chip for Rapid Detection of Sepsis
  • 🏅 Biophysics in Africa Conference (Sept. 2023)
    • African Light Source and African Physical Society
  • 🎖️ Certificate of Participation (Nov. 2023)
    • African Light Source and African Physical Society
  • 🏆 Certificate of Award (June 2023)
    • Key Performance Indicators for Government Effectiveness in Africa, Egypt
  • 🎓 E-JUST TICAD7 Scholarship Award (Feb. 2023 – Present)
    • Egypt-Japan University of Science and Technology
  • 🥇 African Material Research Society Award (Aug. 2021)
    • Winner of Team Project: Theranostics Nanoformulation for TB Therapy & Monitoring
  • 📜 Digital Pedagogy Training (Apr. 2021)
    • Certificate of Participation, FUAM

Publication Top Notes:

Enhanced photoelectrochemical transient photoresponse properties of molybdenum oxide film deposited on black silicon

CITED:17

Elemental composition of dust particles and influence of dust addition on photovoltaic module performance

CITED:4

The analysis of dielectric constant, loss factor and Q-factor of selected fruits at microwave frequency range

CITED:2

Effects of Repeated Frying on Physical Properties of Cooking Oil obtained from Local Markets in Makurdi Metropolis, Benue State, Nigeria.

CITED:1

Enzyme-Free glucose detection in sweat using 2D inkjet-printed cobalt sulfide anchored on graphene in a paper-based microfluidic device

CITED:0

Dr. Zheng Hu | Biosensor Awards | Best Researcher Award

Dr. Zheng Hu | Biosensor Awards | Best Researcher Award

Dr. Zheng Hu, University of Chinese Academy of Sciences , Beijing, China

Dr. Zheng Hu is an Associate Professor and Deputy Director at the Translational Medicine Institute of South China University, based at The First People’s Hospital of Chenzhou, Hunan, China. With a Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences, his research focuses on gene editing technology, cancer biomarkers, and screening of anti-tumor compounds from traditional Chinese herbs. He has made significant contributions to cancer screening and nucleic acid detection, with several publications in high-impact journals. Dr. Hu is also recognized for his work on CRISPR-based detection systems and molecular pathogenesis in various cancers.

Professional Profile:

Orcid

Summary of Suitability:

Dr. Zheng Hu is an outstanding candidate for the Best Researcher Award due to his prolific research contributions, particularly in gene editing and cancer biomarker development. His innovative approach to applying cutting-edge technologies like CRISPR in clinical settings, along with his strong publication record and leadership, makes him highly deserving of recognition. His research has the potential to revolutionize cancer diagnostics and treatments, underscoring his impact in the biomedical field.

🎓Education:

Dr. Zheng Hu earned his Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in Beijing, China, between 2011 and 2014. Prior to that, he completed his M.S. in Genetics from Xiangya Medical School of Central South University in Changsha, China, from 2001 to 2005. He also holds a B.S. in Biology, which he obtained from the School of Life Science at Central China Normal University in Wuhan, China, during 1994 to 1998.

🏢Work Experience:

Dr. Zheng Hu has held the position of Associate Professor at the Translational Medicine Institute of South China University, located at The First People’s Hospital of Chenzhou, Hunan, China, since 2018. Prior to this role, he worked as a Postdoctoral Research Fellow at Xiangya Hospital, Central South University, in Changsha, from 2015 to 2018. Between 2014 and 2015, Dr. Hu served as an Assistant Investigator at the same institute where he is now a professor. He also worked as an Assistant Investigator at the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, from 2010 to 2011, and as a Research Associate at the same institute from 2005 to 2010. Earlier in his career, between 1998 and 2001, he was a Technician and Teaching Assistant at Xiangya Medical School of Central South University in Changsha.

🏅Awards and Honors:

Dr. Zheng Hu is recognized for his significant contributions to the development of CRISPR-based detection systems and cancer biomarker research. He has published extensively in high-impact journals, earning recognition for his advancements in cancer screening and gene editing technology. His work has greatly influenced the fields of translational medicine and molecular biology, showcasing innovative approaches to cancer detection and treatment.

Publication Top Notes:

  1. Targeted disruption of the BCR-ABL fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells
  2. Rapid, portable Epstein‒Barr virus DNA detection using enzymatic recombinase amplification combined with the CRISPR–Cas12a system
  3. CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma
  4. SARS-CoV-2 and Its Omicron Variants Detection with RT-RPA-CRISPR/Cas13a-Based Method at Room Temperature
  5. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression